Increased frequency of IgG heavy chain marker Glm(2) and of HLA-B8 in Lambert-Eaton myasthenic syndrome with and without associated lung carcinoma.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Human Immunology

• Publication date

  1985-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0198-8859(85)90062-XPMID 2993207
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma exchange and immunosuppressive drug treatment in the Lambert‐Eaton myasthenic syndrome

  1984cited by this paper
• Passive Transfer of Lambert‐Eaton Myasthenic Syndrome in Mice: Decreased Rates of Resting and Evoked Release of Acetylcholine from Skeletal Muscle

  1984cited by this paper
• Transcriptional activation of the translocated c-myc oncogene in burkitt lymphoma.

  1983cited by this paper
• Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones.

  1983cited by this paper
• Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse.

  1983cited by this paper
• Eaton‐Lambert syndrome

  1982cited by this paper
• Autoimmunity in the Lambert-Eaton myasthenic syndrome.

  1982cited by this paper
• Heterozygosity at Gm loci associated with humoral immunity to osteosarcoma

  1982cited by this paper
• Paucity and disorganization of presynaptic membrane active zones in the lambert‐eaton myasthenic syndrome

  1982cited by this paper
• The genetic basis of antibody production: The dominant anti‐arsonate idiotype response of the strain a mouse

  1982cited by this paper
• Lambert-Eaton myasthenic syndrome: electrophysiological evidence for a humoral factor.

  1982cited by this paper
• IMMUNOGLOBULIN (Gm) ALLOTYPE FREQUENCIES IN PATIENTS WITH RENAL FAILURE

  1982cited by this paper
• Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome.

  1981cited by this paper
• Interaction of HLA and Gm in autoimmune chronic active hepatitis.

  1981cited by this paper
• Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis.

  1980cited by this paper
• Linkage between the frequency of muscular weakness and loci that regulate immune responsiveness in murine experimental myasthenia gravis

  1980cited by this paper
• IgG heavy chain allotypes (Gm) in autoimmune diseases.

  1980cited by this paper
• Two types of somatic recombination are necessary for the generation of complete immunoglobulin heavy-chain genes

  1980cited by this paper
• Cholinergic dysautonomia and Eaton‐Lambert syndrome

  1979cited by this paper
• Gene frequencies in a Dutch population.

  1974cited by this paper
• The Eaton-Lambert syndrome and autoimmune disorders.

  1972cited by this paper
• QUANTAL COMPONENTS OF END‐PLATE POTENTIALS IN THE MYASTHENIC SYNDROME *

  1971cited by this paper
• Frequency of Certain Gm and Inv Factors in the United Kingdom

  1968cited by this paper
• Electromyography and electric stimulation of nerves in diseases of motor unit; observations on myasthenic syndrome associated with malignant tumors.

  1957cited by this paper
• Defect of neuromuscular conduction associated with malignant neoplasm

  1956cited by this paper

• Lambert-Eaton myasthenic syndrome.

  2024cites this paper
• Associations between HLA and autoimmune neurological diseases with autoantibodies

  2020cites this paper
• Neuromuscular junction disorders.

  2016cites this paper
• Lambert–Eaton Myesthenic Syndrome and Brain Metastasis from Occult Small Cell Lung Carcinoma: A Clinician’s Perspective

  2014cites this paper
• Hereditary and Autoimmune Myasthenias

  2013cites this paper
• Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS.

  2011cites this paper
• 3,4-diaminopyridine for the treatment of Lambert–Eaton myasthenic syndrome

  2010cites this paper
• The clinical DELTA-P score accurately predicts small cell lung cancer in the Lambert-Eaton myasthenic syndrome

  2010cites this paper
• Lambert-Eaton Syndrome

  2009cites this paper
• Lambert-Eaton myasthenic syndrome.

  2009cites this paper
• Lambert–Eaton Myasthenic Syndrome

  2008cites this paper
• [Lambert-Eatone myastenic syndrome].

  2006cites this paper
• HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome.

  2005cites this paper
• Immunopathology of the Lambert-Eaton myasthenic syndrome

  2004cites this paper
• Lambert-Eaton myasthenic syndrome

  2004cites this paper
• High innate production of interleukin-10 and tumor necrosis factor-alpha contributes to susceptibility for non-paraneoplastic Lambert-Eaton myasthenic syndrome.

  2003cites this paper
• High innate production of interleukin-10 and tumor necrosis factor-α contributes to susceptibility for non-paraneoplastic Lambert–Eaton myasthenic syndrome

  2003cites this paper
• Ca2+ Channels as Targets of Neurological Disease: Lambert–Eaton Syndrome and Other Ca2+ Channelopathies

  2003cites this paper
• HLA‐B8 in Patients with the Lambert‐Eaton Myasthenic Syndrome Reduces Likelihood of Associated Small Cell Lung Carcinoma

  2003cites this paper
• Pathogenic Autoantibodies in the Lambert‐Eaton Myasthenic Syndrome

  2003cites this paper
• HLA class I and II in Lambert-Eaton myasthenic syndrome without associated tumor.

  2001cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2001cites this paper
• Idiopathic Lambert-Eaton myasthenic syndrome associated with minimal-change glomerulonephritis and psoriatic arthritis

  2001influential citation
• Increased frequency of HLA class II alleles DRB1*0301 and DQB1*0201 in Lambert-Eaton myasthenic syndrome without associated cancer.

  2000cites this paper
• Lambert-Eaton myasthenic syndrome

  1999cites this paper
• Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.

  1998cites this paper
• Disorders of the Human Neuromuscular Junction

  1997cites this paper
• Immunology of the motor nerve terminal

  1994cites this paper
• Lambert-Eaton myasthenic syndrome and polyneuropathy in a patient with epidermoid carcinoma of the lung.

  1993cites this paper
• Autoantibody Specificities in Lambert‐Eaton Myasthenic Syndrome

  1993cites this paper
• Lambert-Eaton myasthenic syndrome associated with Sjögren's syndrome and discoid lupus erythematosus.

  1993cites this paper
• [Autoimmunity and cancer: paraneoplastic neurological syndromes associated with small cell cancer].

  1992cites this paper
• Immunocytochemical characteristics of small cell lung carcinoma associated with the Lambert-Eaton myasthenic syndrome.

  1992cites this paper
• Immunological evidence fortheco-existence of theLambert-Eaton myasthenic syndrome and myasthenia gravis intwopatients

  1991cites this paper
• The contribution of non-MHC genes to susceptibility to autoimmune diseases.

  1991cites this paper
• [Lambert-Eaton myasthenic syndrome. Physiopathological aspects and therapeutic modalities].

  1991cites this paper
• Immunological evidence for the co-existence of the Lambert-Eaton myasthenic syndrome and myasthenia gravis in two patients.

  1991cites this paper
• Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.

  1991cites this paper
• Myasthenie im Alter

  1989cites this paper
• Anti-neuronal autoantibodies and neurological paraneoplastic syndromes.

  1989cites this paper
• Neuronal antinuclear antibodies in a patient with Lambert‐Eaton myasthenic syndrome and small‐cell lung carcinoma

  1989cites this paper
• Gm allotype system and autoimmune diseases

  1989cites this paper
• Lambert-Eaton syndrome antibodies: reaction with membranes from a small cell lung cancer xenograft.

  1988cites this paper
• The Lambert-Eaton myasthenic syndrome. A review of 50 cases.

  1988cites this paper
• Humoral factors in inflammatory disorders of the central and peripheral nervous system.

  1988cites this paper
• Lambert-Eaton myasthenic syndrome: a review.

  1988cites this paper
• Autoimmunity in Neuromuscular Disease

  1988cites this paper
• Associations of the Autoimmune Myasthenias with Genetic Markers in the Immunoglobulin Heavy Chain Region a

  1988cites this paper
• Abnormalities of autonomic function in the Lambert Eaton myasthenic syndrome.

  1988cites this paper
• Immunogenetics: genetic polymorphism and susceptibility to neurological disease

  1988cites this paper
• Immunoglobulin allotypes Gm and Km in hematologic malignancies.

  1988cites this paper
• Lambert‐Eaton myasthenic syndrome: II. Immunoelectron microscopy localization of IgG at the mouse motor end‐plate

  1987cites this paper
• Deficiency of the effector mechanisms of the immune response and autoimmunity.

  1987cites this paper
• Immunological Heterogeneity and Cellular Mechanisms in Myasthenia Gravis a

  1987cites this paper
• Susceptibility to multiple sclerosis associated with an immunoglobulin gamma 3 restriction fragment length polymorphism.

  1987cites this paper
• Immunoglobulin heavy chain switch region restriction fragment length polymorphisms are associated with renal disease.

  1986cites this paper
• Increased frequency of Gm(1,2;21) phenotype in HLA-DR4 positive seropositive rheumatoid arthritis.

  1986cites this paper
• Gm and Km allotypes, immune response and disease susceptibility.

  1986cites this paper
• Multiple Sclerosis and Myasthenia Gravis

  1985cites this paper
• Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line

  1985cites this paper